DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives $28.40 Consensus PT from Analysts

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has been assigned a consensus rating of “Hold” from the twelve brokerages that are covering the company, Marketbeat reports. Seven research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $27.91.

A number of research analysts have issued reports on XRAY shares. Barrington Research decreased their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. Leerink Partners lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. UBS Group dropped their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a report on Tuesday, December 3rd. Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, November 8th. Finally, Evercore ISI dropped their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of XRAY. Synovus Financial Corp acquired a new stake in shares of DENTSPLY SIRONA in the 3rd quarter valued at approximately $240,000. Tidal Investments LLC acquired a new stake in DENTSPLY SIRONA in the third quarter valued at $602,000. Wilmington Savings Fund Society FSB bought a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at about $261,000. M&T Bank Corp increased its stake in shares of DENTSPLY SIRONA by 5.6% during the 3rd quarter. M&T Bank Corp now owns 39,079 shares of the medical instruments supplier’s stock worth $1,058,000 after purchasing an additional 2,062 shares during the last quarter. Finally, Barclays PLC raised its holdings in shares of DENTSPLY SIRONA by 21.8% in the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock valued at $8,301,000 after purchasing an additional 54,920 shares during the period. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock opened at $18.70 on Monday. The firm has a market capitalization of $3.72 billion, a P/E ratio of -9.03, a PEG ratio of 1.93 and a beta of 0.96. The business has a 50-day moving average of $20.72 and a 200-day moving average of $23.90. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a 1 year low of $17.21 and a 1 year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating the consensus estimate of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.49 earnings per share. On average, equities analysts anticipate that DENTSPLY SIRONA will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, December 27th. This represents a $0.64 annualized dividend and a yield of 3.42%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -30.92%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.